2025 Partners
Program Partner
Adimab
Adimab is the most successful antibody discovery company in the industry, with 450+ discovery campaigns and 55+ clinical programs created with more than 100 partners. Our unique, yeast-based platform is a comprehensive and effective tool for the discovery and optimization of fully human monoclonal and bispecific antibodies. Our partners range from some of the biggest pharma to biotech companies at all stages to leading academic institutions. We’re committed to staying at the cutting edge
of protein-based therapeutic discovery to enable the highest quality IgGs, multispecifics, CARs and other modalities to allow our partners to have the most successful therapeutic programs possible.
Program Partner
Alloy Therapeutics
Keyway TCR Discovery is a proprietary, integrated, end-to-end service for generating highly specific therapeutically-optimized TCR mimic leads. From immunizing our industry-leading ATXGx mice with high-quality protein-HLA complexes to pairing in vitro and AI/ML capabilities for broad developability and specificity screening, to state-of-art engineering and bespoke functional screening capabilities, Keyway TCR Discovery creates leads you can develop with confidence.
Hosting Partner
Miltenyi Biotec
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative technologies enable solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer. Miltenyi Biotec has more than 4,700 employees in 23 countries.